Relevant bibliographies by topics / Lipodystrophy management

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Lipodystrophy management'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lipodystrophy management.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lipodystrophy management"

1

Njelekela, Marina, Rose Mpembeni, Alfa Muhihi, Nzovu Ulenga, Eric Aris, and Deodatus Kakoko. "Lipodystrophy among HIV-Infected Patients Attending Care and Treatment Clinics in Dar es Salaam." AIDS Research and Treatment 2017 (2017): 1–10. http://dx.doi.org/10.1155/2017/3896539.

Full text
Abstract:
Background. HIV infection and long-term HAART use are associated with metabolic and morphological changes. We assessed prevalence, types, and risk factors associated with lipodystrophy among HIV-infected adults attending CTC in Dar es Salaam, Tanzania. Methods. Analysis included 466 HIV-infected patients. Study protocol involved administration of structured questionnaire to collect sociodemographic and clinical information. Diagnosis of lipodystrophy was based on physician clinical assessment. Results. Lipodystrophy was present in 95 (20.4%) of the study participants, with lipoatrophy being th
APA, Harvard, Vancouver, ISO, and other styles
2

Thappa, Devinder Mohan. "Gynoid lipodystrophy – clinical and management issues." Cosmoderma 2 (September 14, 2022): 82. http://dx.doi.org/10.25259/csdm_96_2022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hultman, C. Scott, Lindsee E. McPhail, Jeffrey H. Donaldson, and David A. Wohl. "Surgical Management of HIV-Associated Lipodystrophy." Annals of Plastic Surgery 58, no. 3 (2007): 255–63. http://dx.doi.org/10.1097/01.sap.0000248128.33465.83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pirmohamed, Munir. "Clinical management of HIV-associated lipodystrophy." Current Opinion in Lipidology 20, no. 4 (2009): 309–14. http://dx.doi.org/10.1097/mol.0b013e32832d3bb1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gautama, Hendra Ikhwan, and Jongky Hendro Prajitno. "A rare lipodystrophy syndrome with familial partial lipodystrophy 2 (FPLD2)." Bali Medical Journal 12, no. 3 (2023): 2424–29. http://dx.doi.org/10.15562/bmj.v12i3.4518.

Full text
Abstract:
Background: Lipodystrophy (LD) syndromes are a diverse group of ultra-rare diseases characterized by adipose tissue deficiency, resulting in potentially severe metabolic disturbances. Due to their scarcity, diagnosis and management are often challenging for clinicians. This study aimed to report a rare case of LD syndromes, as well their diagnosis and possible management. Case Presentation: A 27-year-old female presented to Dr. Soetomo General Academic Hospital, Surabaya, Indonesia with a chief complaint of abdominal (epigastric) pain, accompanied by diarrhea, nausea, and vomiting. The patient
APA, Harvard, Vancouver, ISO, and other styles
6

Garg, Abhimanyu. "Lipodystrophies: Genetic and Acquired Body Fat Disorders." Journal of Clinical Endocrinology & Metabolism 96, no. 11 (2011): 3313–25. http://dx.doi.org/10.1210/jc.2011-1159.

Full text
Abstract:
Abstract Context: Lipodystrophies are heterogeneous, genetic or acquired disorders characterized by selective loss of body fat and predisposition to insulin resistance. The extent of fat loss determines the severity of associated metabolic complications such as diabetes mellitus, hypertriglyceridemia, and hepatic steatosis. Evidence Acquisition and Synthesis: Both original and review articles were found via PubMed search reporting on clinical features and management of various types of lipodystrophies and were integrated with the author's knowledge of the field. Conclusion: The autosomal reces
APA, Harvard, Vancouver, ISO, and other styles
7

Gold, Daniel R., and Donald J. Annino. "HIV-Associated Cervicodorsal Lipodystrophy: Etiology and Management." Laryngoscope 115, no. 5 (2005): 791–95. http://dx.doi.org/10.1097/01.mlg.0000161838.22766.88.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Davison, Steven P., Joseph Timpone, and Catherine M. Hannan. "Surgical Algorithm for Management of HIV Lipodystrophy." Plastic and Reconstructive Surgery 120, no. 7 (2007): 1843–58. http://dx.doi.org/10.1097/01.prs.0000267341.14550.a7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bodasing, N., and R. Fox. "HIV-associated Lipodystrophy Syndrome: Assessment and Management." Journal of Infection 46, no. 2 (2003): 87–93. http://dx.doi.org/10.1053/jinf.2002.1103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Foss-Freitas, Maria C., Baris Akinci, Yingying Luo, Andra Stratton, and Elif A. Oral. "Diagnostic strategies and clinical management of lipodystrophy." Expert Review of Endocrinology & Metabolism 15, no. 2 (2020): 95–114. http://dx.doi.org/10.1080/17446651.2020.1735360.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Lipodystrophy management"

1

Loonam, Cathriona Rosemary. "Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome." Thesis, King's College London (University of London), 2015. http://kclpure.kcl.ac.uk/portal/en/theses/prevalence-underlying-mechanisms-and-role-of-nutrition-in-the-management-of-the-hivassociated-lipodystrophy-syndrome(fbe1f1ae-e564-4b1c-ad91-bdc33b37cae8).html.

Full text
Abstract:
HIV-associated lipodystrophy syndrome (HALS) is characterised by abnormalities of body fat distribution and metabolism resulting from adipocyte dysfunction. This thesis examines the hypothesis that antiretroviral drugs (ARVs) alter PPAR-γ, which contributes to adipocyte dysfunction. We hypothesise that conjugated linoleic acid (CLA) isomers, as putative PPAR-γ ligands, will attenuate adipocyte dysfunction and HALS. In vitro, ritonavir (RTV; 20 μM) was the most potent ARV and significantly decreased triglyceride storage (P < 0.001), perilipin (P = 0.003) and Cidea expression (P < 0.001), PPAR-γ
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Lipodystrophy management"

1

Pereira, Luis F., Harold W. Goforth, Esteban Martínez, Joseph Z. Lux, Maria Ferrara, and Michael P. Mullen. Cardiovascular Disease, Metabolic Complications and Lipodystrophy in Persons with HIV. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0046.

Full text
Abstract:
The introduction of effective antiretroviral therapy has contributed to a dramatic reduction in HIV-related mortality. As patients live longer, evidence suggests an increased incidence of cardiovascular disease in persons with HIV over that among individuals who do not have HIV, thus early detection and treatment of multimorbidities and modifiable cardiovascular disease risk factors particularly in persons with HIV are needed. Several mechanisms have been proposed to explain the increased risk of cardiovascular disease, including the virus itself, antiretroviral therapy, and traditional risks
APA, Harvard, Vancouver, ISO, and other styles
2

Jäger, Hans, and Stefan Mauss. AIDS- Lipodystrophie. Pathologische Grundlagen und klinisches Management. Thieme, Stuttgart, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lipodystrophy management"

1

Hultman, C. Scott, and Anne Keen. "Management of HIV-Associated Lipodystrophy: Medical and Surgical Options for Lipoatrophy and Lipohypertrophy." In Body Contouring. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-02639-3_54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Brew, Bruce James. "Medication-Related Myopathy." In HIV Neurology. Oxford University PressNew York, NY, 2001. http://dx.doi.org/10.1093/oso/9780195133639.003.0024.

Full text
Abstract:
Abstract Several medications used in the management of human immunodeficiency virus (HIV) disease may cause a myopathy. Chief among these is zidovudine. With the lower doses that are currently used, zidovudine is not as common a cause of myopathy as it once was. Higher than normal doses of zidovudine in combination with other antiretroviral drugs are sometimes, however, still required for the treatment of neurologic complications, especially acquired immunodeficiency syndrome (AIDS) dementia complex. Moreover, the increasing incidence of lipodystrophy and its associated hyperlipidemia has brou
APA, Harvard, Vancouver, ISO, and other styles
3

Owen, Katharine R. "Diagnosis of Non Type 1, Non Type 2 Forms of Diabetes." In Oxford Textbook of Endocrinology and Diabetes 3e, edited by John A. H. Wass, Wiebke Arlt, and Robert K. Semple. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198870197.003.0249.

Full text
Abstract:
Diabetes that is neither type 1 nor type 2 in aetiology accounts for around 5% of cases, with a wide range of causes. The widest differential diagnosis is in the young adult group. Non-type 1/type 2 diabetes includes monogenic causes of both beta-cell dysfunction (MODY, neonatal diabetes, mitochondrial diabetes) and insulin resistance (lipodystrophy, insulin receptor defects and monogenic obesity), as well as pancreatic, endocrine, and syndromic causes. It is important to make the correct aetiological diagnosis as this is likely to affect treatment and other aspects of management as well as de
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lipodystrophy management"

1

Ur Rehman, Sami. "P158 Anaesthesia management of berardinelli-seip congenital lipodystrophy." In ESRA Abstracts, 41st Annual ESRA Congress, 4–7th September 2024. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/rapm-2024-esra.354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mohamed, Fatma, Carl Nelson, and Yucheng Li. "Design of Automated Insulin Needle Dispenser for Diabetes Care." In 2025 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2025. https://doi.org/10.1115/dmd2025-1057.

Full text
Abstract:
Abstract Diabetes affects a significant portion of the global population, with 11.6% of individuals in the United States living with this chronic condition. Many patients rely on insulin injections for the daily management of their blood glucose levels. However, approximately 50% of insulin users reuse needles, which significantly increases the risk of infections, lipodystrophy, and painful injections due to needle deformation. Current technological advancements in diabetes care focus on insulin pumps, continuous glucose monitoring systems, and mobile applications, yet needle hygiene remains a
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Lipodystrophy management' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography